CRISPR and Genome Editing – Products

Under the new agreement, Integrated DNA Technologies (IDT) will sell Aldevron cGMP-manufactured CRISPR nucleases to enable customers to rapidly transition from discovery to clinic.

New optical technology aims to expedite and enhance the development of viral vectors and gene therapies.

Form Bio, announced capabilities for cell and gene therapy companies to rapidly model billions of potential construct candidates.

Adeno-associated viral vector (AAV) has become a preferred gene therapy delivery modality; however, AAV manufacturing is not without its challenges, whether that is using crude samples, a lack of standardized methods or incompatible techniques.

Ganymede Bio and Kytopen have announced a partnership to bring the power of cloud-native, structured data to Kytopen’s Flowfect® platforms.

Curiox Biosystems announces its collaboration with Dr. Marco Ruella, an assistant professor of medicine at the Perelman School of Medicine, to support efforts in the development of next-generation cancer cell therapies.

A scalable and robust solution for all stages of the gene therapy workflow to meet regulatory standards is essential, however, as the field is more recent, liquid media is the common format even though it can be more expensive and have a shorter shelf life.

TherageniX, have been awarded a £995,000 grant from Innovate UK. The funding will support the development of the Company’s gene therapy in a powder, a non-viral gene delivery system to improve tissue regeneration following surgery.

Scale Biosciences, Inc. announced an expansion of their product portfolio to enable a broader range of single cell omics experiments and unlock new translational research applications.

Polyplus (now part of Satorius), is announcing the pre-order availability of FectoVIR®-LV transfection reagent for lentiviral vector (LV) production.